Patent strategies for therapeutic RNAi

Author： Highlander Steven L   Wohlers Travis M  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.18, Iss.11, 2008-11, pp. : 1289-1298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS

By Orlacchio Antonio   Bernardi Giorgio   Orlacchio Aldo   Martino Sabata  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 10, 2008-10 ,pp. : 1161-1174

Informa Healthcare

Access to resources Recommend Favorite

Novel Therapeutic Strategies in Major Depression: Focus on RNAi and Ketamine

By  

Current Pharmaceutical Design, Vol. 20, Iss. 23, 2014-01 ,pp. : 3848-3860

Bentham Science Publishers

Access to resources Recommend Favorite

Patent strategies in the antisense oligonucleotide based therapeutic approach

By Craig A.   Vanstone D.   Agrawal S.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1175-1182

Informa Healthcare

Access to resources Recommend Favorite

RNAi Screening for Therapeutic Targets in Human Malignancies

By  

Current Pharmaceutical Biotechnology, Vol. 8, Iss. 6, 2007-12 ,pp. : 337-343

Bentham Science Publishers

Access to resources Recommend Favorite

Prostate cancer: therapeutic patent review

By Sepp-Lorenzino L.   Slovin S.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 12, 2000-12 ,pp. : 1833-1842

Informa Healthcare

Access to resources Recommend Favorite